An exploratory case series of sequential stereotactic body radiotherapy and tislelizumab after platinum-doublet chemotherapy in stage IIIB/C–IV non-squamous NSCLC - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Pilot Case Series Investigating the Efficacy of Sequential Stereotactic Body Radiotherapy and Tislelizumab Following Platinum-Doublet Chemotherapy in Patients with Stage IIIB/C–IV Non-Squamous Non-Small Cell Lung Cancer

  • By

  • Shanshan Li

  • Feng Du

  • Changjun Leng

  • Jianjian Dou

  • Jian Shi

  • Yan Zhang

  • Feifei Lu

  • Qiang Wang

  • September 7, 2026

Share

Original Source(s)

Related Content